Catabolic efficiency of aerobic glycolysis: The Warburg effect revisited

BMC Systems Biology

Volumn 4, Issue , 2010, Pages

  Vazquez, Alexei ^a   Liu, Jiangxia ^b   Zhou, Yi ^b   Oltvai, Zoltán N ^b  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSECTIVORA; MAMMALIA;

ADENOSINE TRIPHOSPHATE; GLUCOSE; LACTIC ACID DERIVATIVE;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; CATALYSIS; ENERGY METABOLISM; FIBROBLAST; GENETICS; GLYCOLYSIS; HUMAN; METABOLISM; MITOCHONDRION; MOUSE; OXYGEN CONSUMPTION; PHENOTYPE; PHYSIOLOGY; SYSTEMS BIOLOGY;

ADENOSINE TRIPHOSPHATE; ANIMALS; CATALYSIS; ENERGY METABOLISM; FIBROBLASTS; GLUCOSE; GLYCOLYSIS; HUMANS; LACTATES; MICE; MITOCHONDRIA; MODELS, BIOLOGICAL; OXYGEN CONSUMPTION; PHENOTYPE; SYSTEMS BIOLOGY;

EID: 77951803596     PISSN: None     EISSN: 17520509     Source Type: Journal    
DOI: 10.1186/1752-0509-4-58     Document Type: Article

References (39)

1. Warburg O. On the origin of cancer cells. Science 1956, 123:309-314. 10.1126/science.123.3191.309, 13298683.
2. Brahimi-Horn MC, Chiche J, Poyssegur J. Hypoxia signaling controls metabolic demand. Curr Opin Cell Biol 2007, 19:223-229. 10.1016/j.ceb.2007.02.003, 17303407.
3. Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis?. Nature Rev Cancer 2004, 4:891-899.
4. Zu XL, Guppy M. Cancer metabolism: facts, fantasy, and fiction. Biochem Biophys Res Comm 2004, 313:459-465. 10.1016/j.bbrc.2003.11.136, 14697210.
5. Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg Effect: The metabolic requirements of cell proliferation. Science 2009, 324:1029-1033. 2849637, 19460998, 10.1126/science.1160809.
6. Wieman HL, Wofford JA, Rathmell JC. Cytokine stimulation promotes glucose uptake via phosphatidylinositol-3 kinase/Akt regulation of Glut1 activity and trafficking. Mol Biol Cell 2007, 18:1437-1446. 1838986, 17301289, 10.1091/mbc.E06-07-0593.
7. Copeland WC, Wachsman JT, Johnson FM, Penta JS. Mitochondrial DNA alterations in cancer. Cancer Invest 2002, 20:557-569. 10.1081/CNV-120002155, 12094550.
8. Nomoto S, Sanchez-Cespedes M, Sidransky D. Identification of mtDNA mutations in human cancer. Methods Mol Biol 2002, 197:107-117.
9. Carew JS, Zhou Y, Albitar M, Carew JD, Keating MJ, Huang P. Mitochondrial DNA mutations in primary leukemia cells after chemotherapy: clinical significance and therapeutic implications. Leukemia 2003, 17:1427-1447.
10. Pelicano H, Xu RH, Du M, Feng L, Sasaki R, Carew JS, Hu Y, Ramdas L, Hu L, Keating MJ, Zhang W, Plunkett W, Huang P. Mitochondrial respiration defects in cancer cells cause activation of Akt survival pathway through a redox-mediated mechanism. J Cell Biol 2006, 175:913-932. 2064701, 17158952, 10.1083/jcb.200512100.
11. Matoba S, Kang JG, Patino WD, Wragg A, Boehm M, Gavrilova O, Hurley PJ, Bunz F, Hwang PM. p53 regulates mitochondrial respiration. Science 2006, 312:1650-1653. 10.1126/science.1126863, 16728594.
12. Bensaad K, Tsuruta A, Selak MA, Vidal MN, Bartrons R, Gottlieb E, Vousden KH. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 2006, 126:117-120.
13. Kroemer G, Pouyssegur J. Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell 2008, 13:472-482. 10.1016/j.ccr.2008.05.005, 18538731.
14. Christofk HR, Heiden MG, Harris MH, Ramanathan A, Gerszten RE, Wei R, Fleming MD, Schreiber SL, Cantley LC. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 2008, 452:230-3. 10.1038/nature06734, 18337823.
15. Ellis RJ. Macromolecular crowding: obvious but underappreciated. Trends Biochem Sci 2001, 26:597-604. 10.1016/S0968-0004(01)01938-7, 11590012.
16. Hall D, Minton AP. Macromolecular crowding: qualitative and semi-quantitative successes, quantitative challenges. Biochim Biophys Acta 2003, 1649:127-39.
17. Sinclair R. Response of mammalian cells to controlled growth rates in steady-state continuous culture. In Vitro 1974, 10:295-305. 10.1007/BF02615311, 4616003.
18. Gambhir A, Korke R, Lee J, Fu P-C, Europa A, Hu W-S. Analysis of cellular metabolism of hybridoma cells at distinct physiological states. J Biosci Bioeng 2003, 95:317-327.
19. Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, Weinberg RA. Creation of human tumour cells with defined genetic elements. Nature 1999, 400:464-468. 10.1038/22780, 10440377.
20. Ramanathan A, Wang C, Schreiber SL. Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements. Proc Natl Acad Sci USA 2005, 102:5992-7. 1087961, 15840712, 10.1073/pnas.0502267102.
21. de Groof AJ, te Lindert MM, van Dommelen MM, Wu M, Willemse M, Smift AL, Winer M, Oerlemans F, Pluk H, Fransen JA, Wieringa B. Increased OXPHOS activity precedes rise in glycolytic rate in H-RasV12/E1A transformed fibroblasts that develop a Warburg phenotype. Mol Cancer 2009, 8:54. 2734543, 19646236, 10.1186/1476-4598-8-54.
22. Sweeney MJ, Ashmore J, Morris HP, Weber G. Comparative biochemistry of hepatomas. IV. Isotope studies of glucose and fructose metabolism in liver tumors of different growth rates. Cancer Res 1963, 23:995-1002.
23. Lee HC, Yin PH, Lin JC, Wu CC, Chen CY, Wu CW, Chi CW, Tam TN, Wei YH. Mitochondrial genome instability and mtDNA depletion in human cancers. Ann N Y Acad Sci 2005, 1042:109-22. 10.1196/annals.1338.011, 15965052.
24. Lin CS, Wang LS, Tsai CM, Wei YH. Low copy number and low oxidative damage of mitochondrial DNA are associated with tumor progression in lung cancer tissues after neoadjuvant chemotherapy. Interact Cardiovasc Thorac Surg 2008, 7:954-958. 10.1510/icvts.2008.177006, 18685121.
25. Michelakis ED, Webster L, Mackey JR. Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer. Br J Cancer 2008, 99:989-994. 2567082, 18766181, 10.1038/sj.bjc.6604554.
26. Newsholme EA, Crabtee B, Ardawi MSM. The role of high glycolysis and glutamine utilization in rapidly dividing cells. Biosci Rep 1985, 5:393-400. 10.1007/BF01116556, 3896338.
27. DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 2008, 7:11-20. 10.1016/j.cmet.2007.10.002, 18177721.
28. Frick O, Wittmann C. Characterization of metabolic shift between oxidative and fermentative growth in Saccharomyces cerevisiae by comparative 13C flux analysis. Microbial Cell Factories 2005, 4:30. 1291395, 16269086, 10.1186/1475-2859-4-30.
29. Vazquez A, Beg QK, de Menezes MA, Ernst J, Bar-Joseph Z, Barabási A-L, Boros LG, Oltvai ZN. Impact of the solvent capacity constraint on E. coli metabolism. BMC Systems Biol 2008, 2:7.
30. Beg QK, Vazquez A, Ernst J, de Menezes MA, Bar-Joseph Z, Barabási A-L, Oltvai ZN. Intracellular crowding of macromolecules defines the mode and sequence of substrate uptake by Escherichia coli and constrains its metabolic activity. Proc Natl Acad Sci USA 2007, 104:12663-8. 1937523, 17652176, 10.1073/pnas.0609845104.
31. Scopes RK. Studies of reconstituted muscle glycolytic system. Biochem J 1973, 134:197-208. 1177800, 4269207.
32. Lee B. Calculation of volume fluctuations for globular protein models. Proc Natl Acad Sci USA 1983, 80:622-626. 393430, 6572909, 10.1073/pnas.80.2.622.
33. Wibom R, Hultman E, Johansson M, Matherei K, Constantin-Teodosiu D, Schantz PG. Adaptation of mitochondrial ATP production in human skeletal muscle to endurance training and detraining. J Appl Physiol 1992, 73:2004-10.
34. Short KR, Nygren J, Barazzoni R, Levine J, Nair KS. T3 increases mitochondrial production in oxidative muscle despite increased expression of UCP2 and -3. Am J Physiol Endocrinol Metab 2001, 280:E761-E767.
35. Hou X-Y, Green S, Askew CD, Barker G, Green A, Walker PL. Skeletal muscle mitochondrial ATP production rate and walking performance in peripherical arterial disease. Clin Physiol Func Im 2002, 22:226-232.
36. Glass U, Bahr FG. Quantitative study of mitochondria in rat liver. J Cell Biol 1966, 29:507-523. 2106972, 5962940, 10.1083/jcb.29.3.507.
37. Schwerzmann K, Hoppeler H, Kayar SR, Wibel ER. Oxidative capacity of muscle mitochondria. Proc Natl Acad Sci USA 1989, 86:1583-1587. 286742, 2922400, 10.1073/pnas.86.5.1583.
38. Blaker GJ, Pirt SJ. The uptake of vitamins by mouse fibroblast cells (strain LS) during growth in a chemically defined medium. J Cell Sci 1971, 8:709-725.
39. Sen S, Srienc F, Hu W-S. Distinct volume distribution of viable and non-viable hybridoma cells: A flow cytometric study. Cytotechnology 1989, 2:85-94.